mSTAR-1302

N/A

Report date: 2026/02/26 20:00:22

Base Information

Drug NamemSTAR-1302
Drug Alias NamemSTAR-1302mSTAR1302
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionT cell receptor beta variable 13 modulators
TargetsT cell receptor beta variable 13
Therapy Area/IndicationsSquamous Cell Carcinoma of Head and Neck
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMarengo Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesMarengo Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSquamous Cell Carcinoma of Head and Neck
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A